
Italfarmaco and Medis to Distribute Givinostat in 17 Central and Eastern European Countries Including the Baltic States
Italfarmaco S.p.A. and Medis announced an exclusive distribution agreement for givinostat, Italfarmaco’s drug for the treatment of Duchenne muscular dystrophy (DMD). Once approved by the EMA and relevant regulatory bodies, this partnership will facilitate …